Bioqual (OTCMKTS:BIOQ) Releases Quarterly Earnings Results

Bioqual (OTCMKTS:BIOQ) posted its earnings results on Tuesday. The company reported ($1.36) earnings per share (EPS) for the quarter, Zacks reports. Bioqual had a negative return on equity of 2.87% and a negative net margin of 1.99%.

Bioqual Stock Down 3.8 %

Shares of BIOQ opened at $62.50 on Wednesday. The firm has a fifty day simple moving average of $66.46 and a two-hundred day simple moving average of $68.45. Bioqual has a twelve month low of $62.50 and a twelve month high of $80.00. The stock has a market capitalization of $55.63 million, a P/E ratio of -50.81 and a beta of -0.33.

About Bioqual

Bioqual, Inc provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer.